This Biotech Stock 700%: Top Holding After $9.3M Sale
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
Knowing what data is needed for financial analysis is crucial for accurate assessments. Gather the essential information to make informed financial decisions.
26,603 articlesA biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
Cambridge Mobile Telematics has raised $350 million in a strategic round led by TPG Rise Funds and Allianz X, with St...
As AI chatbots expand across industries, investors must weigh price, data controls and performance. This report break...
A new move from Google signals a shift in AI compute. This could tilt the balance away from Nvidia in certain cloud a...
The AI race is intensifying, and investor nerves are on edge. This article breaks down what a potential 'checkmate' m...
Nvidia and Broadcom lead the AI chip market, but which one deserves a place in a modern portfolio? This guide breaks ...
Palantir has moved from hero to a pullback phase. This guide breaks down what its valuation says about the future, wi...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Fresh data suggests U.S. home prices may have found a floor. As affordability stabilizes, demand returns and lenders ...
Investors are debating whether Palantir stock can still deliver. This guide breaks down the growth story, the risks, ...
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
Liquid crypto funds have expanded rapidly, but a looming data and workflow gap threatens risk controls as DeFi strate...